[
    [
        {
            "time": "2018-10-04",
            "original_text": "7 Healthcare Stocks to Buy Right Now",
            "features": {
                "keywords": [
                    "Healthcare",
                    "Stocks",
                    "Buy"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "7 Healthcare Stocks to Buy Right Now",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-10-04",
            "original_text": "Relative Strength Alert For Novo-Nordisk",
            "features": {
                "keywords": [
                    "Relative Strength",
                    "Novo-Nordisk"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Relative Strength Alert For Novo-Nordisk",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-04",
            "original_text": "European ADRs Move Lower in Thursday Trading",
            "features": {
                "keywords": [
                    "European",
                    "ADRs",
                    "Move Lower",
                    "Trading"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "international"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "European ADRs Move Lower in Thursday Trading",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-10-04",
            "original_text": "Lilly's diabetes drug data impresses, hurts rival Novo's shares",
            "features": {
                "keywords": [
                    "Lilly",
                    "diabetes",
                    "drug",
                    "data",
                    "impresses",
                    "rival",
                    "Novo",
                    "shares"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly's diabetes drug data impresses, hurts rival Novo's shares",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-10-04",
            "original_text": "Diabetes Drug's Results Push Lilly to Look at Obesity Too",
            "features": {
                "keywords": [
                    "Diabetes",
                    "Drug",
                    "Results",
                    "Push",
                    "Lilly",
                    "Obesity"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Diabetes Drug's Results Push Lilly to Look at Obesity Too",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-10-04",
            "original_text": "Pre-Market Most Active for Oct 4, 2018: SIR, ARWR, SNAP, QQQ, NVO, BAC, AAPL, SQQQ, TVIX, MNR, FCAU, AU",
            "features": {
                "keywords": [
                    "Pre-Market",
                    "Most Active",
                    "SIR",
                    "ARWR",
                    "SNAP",
                    "QQQ",
                    "NVO",
                    "BAC",
                    "AAPL",
                    "SQQQ",
                    "TVIX",
                    "MNR",
                    "FCAU",
                    "AU"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pre-Market Most Active for Oct 4, 2018: SIR, ARWR, SNAP, QQQ, NVO, BAC, AAPL, SQQQ, TVIX, MNR, FCAU, AU",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 3,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]